Cargando…
Heparin improves BMSC cell therapy: Anticoagulant treatment by heparin improves the safety and therapeutic effect of bone marrow-derived mesenchymal stem cell cytotherapy
Systemic infusion of bone marrow-derived mesenchymal stem cells (BMSCs) has become a promising strategy for disease treatment and tissue regeneration. Strategies to enhance the efficiency of BMSC cell therapy are crucial to promote its clinical application. Here, we aimed to improve BMSC cell therap...
Autores principales: | Liao, Li, Shi, Bingzheng, Chang, Heran, Su, Xiaoxia, Zhang, Lichao, Bi, Chunsheng, Shuai, Yi, Du, Xiaoyan, Deng, Zhihong, Jin, Yan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5196889/ https://www.ncbi.nlm.nih.gov/pubmed/28042320 http://dx.doi.org/10.7150/thno.16911 |
Ejemplares similares
-
Heparin Anticoagulant for Human Bone Marrow Does Not Influence In Vitro Performance of Human Mesenchymal Stromal Cells
por: Roger, Yvonne, et al.
Publicado: (2020) -
Mesenchymal Stem Cells in Renal Fibrosis: The Flame of Cytotherapy
por: Zhuang, Quan, et al.
Publicado: (2019) -
Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022) -
Mesenchymal stem cells in preclinical cancer cytotherapy: a systematic review
por: Christodoulou, Ioannis, et al.
Publicado: (2018) -
Mesenchymal Stem Cells in Preclinical Infertility Cytotherapy: A Retrospective Review
por: Chang, Zhuo, et al.
Publicado: (2021)